NCT02323438View on ClinicalTrials.gov

Assess Biomarkers of Tobacco Exposure and Nicotine Pharmacokinetics in Smokers After a 5-Day In-Clinic Confinement Switch to an Electronic Cigarette or Nicotine Gum

NACompletedINTERVENTIONAL
Enrollment

153

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Smoking
Interventions
OTHER

Usual Brand Cigarette

Combustible cigarette brand style smoked most frequently by subject

OTHER

Electronic Cigarette #1

Electronic cigarette

OTHER

Electronic Cigarette #2

Electronic cigarette

OTHER

Leading U.S. Nicotine Gum

4 mg nicotine polacrilex gum

Trial Locations (1)

55404

DaVita Clinical Research, Minneapolis

Sponsors

Collaborators (1)

Davita Clinical Research
All Listed Sponsors
collaborator

Davita Clinical Research

INDUSTRY

collaborator

RAI Services Company

INDUSTRY

lead

R.J. Reynolds Vapor Company

INDUSTRY

NCT02323438 - Assess Biomarkers of Tobacco Exposure and Nicotine Pharmacokinetics in Smokers After a 5-Day In-Clinic Confinement Switch to an Electronic Cigarette or Nicotine Gum | Biotech Hunter | Biotech Hunter